MORENO, Maria
 Distribuzione geografica
Continente #
NA - Nord America 5.012
AS - Asia 3.402
EU - Europa 2.154
SA - Sud America 562
AF - Africa 105
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 4
AN - Antartide 1
Totale 11.260
Nazione #
US - Stati Uniti d'America 4.646
SG - Singapore 1.178
CN - Cina 1.039
UA - Ucraina 777
DE - Germania 520
BR - Brasile 466
CA - Canada 316
IT - Italia 277
SE - Svezia 168
ID - Indonesia 154
KR - Corea 125
TR - Turchia 113
HK - Hong Kong 111
IN - India 109
VN - Vietnam 102
TH - Thailandia 97
MY - Malesia 95
FR - Francia 94
FI - Finlandia 88
PH - Filippine 73
GB - Regno Unito 56
RU - Federazione Russa 48
BD - Bangladesh 40
PL - Polonia 33
MX - Messico 32
CI - Costa d'Avorio 31
AR - Argentina 29
IQ - Iraq 25
JP - Giappone 22
EU - Europa 20
UZ - Uzbekistan 20
ZA - Sudafrica 20
NL - Olanda 18
PK - Pakistan 18
BE - Belgio 17
VE - Venezuela 17
IR - Iran 16
CO - Colombia 14
ES - Italia 13
JO - Giordania 13
EC - Ecuador 11
MA - Marocco 11
SA - Arabia Saudita 10
CH - Svizzera 9
EG - Egitto 9
PY - Paraguay 9
KE - Kenya 8
NP - Nepal 7
TN - Tunisia 7
PE - Perù 6
AZ - Azerbaigian 5
GT - Guatemala 5
PT - Portogallo 5
DZ - Algeria 4
GR - Grecia 4
JM - Giamaica 4
LT - Lituania 4
PS - Palestinian Territory 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
CL - Cile 3
CR - Costa Rica 3
ET - Etiopia 3
GE - Georgia 3
IE - Irlanda 3
KZ - Kazakistan 3
RS - Serbia 3
RW - Ruanda 3
UY - Uruguay 3
AT - Austria 2
AU - Australia 2
BF - Burkina Faso 2
BG - Bulgaria 2
CY - Cipro 2
EE - Estonia 2
IL - Israele 2
NZ - Nuova Zelanda 2
OM - Oman 2
QA - Qatar 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GM - Gambi 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
Totale 11.248
Città #
Dallas 521
Jacksonville 501
Chandler 485
San Jose 468
Singapore 409
Ashburn 374
The Dalles 342
Toronto 285
Boardman 202
Jakarta 131
Seoul 124
Nanjing 111
Beijing 106
Bremen 106
Hong Kong 104
Princeton 104
Istanbul 101
Bangkok 97
Wilmington 90
Kuala Selangor 65
Munich 64
Shenyang 64
Ann Arbor 62
Dearborn 59
Falkenstein 57
Manila 57
Ogden 53
Boydton 50
Guangzhou 50
Frankfurt am Main 46
Helsinki 46
Los Angeles 41
Shanghai 41
Turku 39
Ho Chi Minh City 37
Jiaxing 37
Columbus 33
Nanchang 32
Abidjan 31
Changsha 30
Hanoi 29
São Paulo 29
Santa Clara 28
Tianjin 28
Hebei 26
Kuala Lumpur 25
Strasbourg 25
Naples 24
Warsaw 24
Council Bluffs 22
Orem 22
Tokyo 22
Leawood 21
Ningbo 21
Mexico City 20
Jinan 19
Tashkent 19
Hillsboro 18
Milan 18
Zhengzhou 18
Augusta 17
Belo Horizonte 17
Brussels 17
Boston 15
Brasília 15
Norwalk 15
San Mateo 15
New York 14
Pune 14
Shenzhen 14
Amman 13
Chennai 13
Brooklyn 12
Hangzhou 12
Mumbai 12
Taizhou 12
Benevento 11
London 11
Rio de Janeiro 11
Rome 11
San Francisco 11
Seattle 11
Stockholm 11
Ardabil 10
Capua 9
Monmouth Junction 9
New Delhi 9
Qingdao 9
San Giorgio Del Sannio 9
Assago 8
Bekasi 8
Buenos Aires 8
Curitiba 8
Dhaka 8
Montreal 8
Ottawa 8
Amsterdam 7
Baghdad 7
Caserta 7
Cebu City 7
Totale 6.556
Nome #
Are the effects of triiodothyronine (T3) on resting metabolism in euthyroid rats entirely due to T3 itself ? 218
Both 3,5-Diiodo-L-Thyronine and 3,5,3'-Triiodo-L-Thyronine Prevent Short-term Hepatic Lipid Accumulation via Distinct Mechanisms in Rats Being Fed a High-Fat Diet. 186
Effect of 3,3’-diiodo-L-thyronine and 3,5-diiodo-L-thyronine on rat liver oxidative capacity 178
3,5-diiodo-L-thyronine increases resting metabolic rate and reduces body weight without undesirable side effects 176
Calorigenic effect of diiodothyronines 167
3,5-Diiodo-L-thyronine rapidly enhances mitochondrial fatty acid oxidation rate and thermogenesis in rat skeletal muscle: AMP-activated protein kinase involvement 153
3,5-diiodo-L-thyronine and 3,5,3'-triiodo-L-thyronine both improve the cold tolerance of hypothyroid rats, but possibly via different mechanisms 152
(Healthy) ageing: Focus on iodothyronines 148
3,5-Diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats 147
3,5 Diiodo-l-Thyronine (T-2) Promotes the Browning of White Adipose Tissue in High-Fat Diet-Induced Overweight Male Rats Housed at Thermoneutrality 146
3,5-diiodo-L-thyronine affects structural and metabolic features of skeletal muscle mitochondria in high-fat-diet fed rats producing a co-adaptation to the glycolytic fiber phenotype 145
Alterations of brain and cerebellar proteomes linked to Aβ and tau pathology in a female triple-transgenic murine model of Alzheimer's disease. 141
3,5-diiodothyronine (T2) induces calcium oscillations and NO release in GH3 cells 137
3,5,3'-Triiodo-L-Thyronine- and 3,5-Diiodo-L-Thyronine- Affected Metabolic Pathways in Liver of LDL Receptor Deficient Mice 134
Mitochondrial Actions of Thyroid Hormone 133
Action of thyroid hormones at the cellular level: the mitochondrial target 132
3,5-Diiodo-L-thyronine prevents high-fat-diet-induced insulin resistance in rat skeletal muscle through metabolic and structural adaptations 131
Peroxisome Proliferator-Activated Receptor Delta: A Conserved Director of Lipid Homeostasis through Regulation of the Oxidative Capacity of Muscle 128
3, 5-diiodothyronine: Biological actions and therapeutic perspectives 128
3,5-Diiodo-L-Thyronine Exerts Metabolically Favorable Effects on Visceral Adipose Tissue of Rats Receiving a High-Fat Diet 127
3,5-diiodo-L-thyronine prevents high fat diet-induced skeletal muscle mitochondrial dysfunctions: an integrated approach 126
3,5-Diiodo-L-thyronine regulates glucose-6-phosphate dehydrogenase activity in the rat 126
3,5-Diiodothyronine: A Novel Thyroid Hormone Metabolite and Potent Modulator of Energy Metabolism 125
Differential effects of 3,5-Diiodo-L-Thyronine and 3,5,3'-Triiodo-L-Thyronine on mitochondrial respiratory pathways in liver from hypothyroid rats 124
Defining the transcriptomic profile of rat ageing skeletal muscle using cDNA array, 2D- and Blue Native-PAGE 124
3,5-diiodo-L-thyronine: a possible pharmacological agent? 123
The saturation degree of fatty acids and their derived acylcarnitines determines the direct effect of metabolically active thyroid hormones on insulin sensitivity in skeletal muscle cells 122
3,5-Diiodo-L-Thyronine (T2) Administration Affects Visceral Adipose Tissue Inflammatory State in Rats Receiving Long-Lasting High-Fat Diet 122
Both 3,3',5-triiodothyronine and 3,5-diodo-L-thyronine Are Able to Repair Mitochondrial DNA Damage but by Different Mechanisms 120
Induction of UCP2 mRNA by thyroid hormones in rat heart 119
Ablation of uncoupling protein 3 affects interrelated factors leading to lipolysis and insulin resistance in visceral white adipose tissue 114
Fenofibrate activates the biochemical pathways and the de novo expression of genes related to lipid handling and uncoupling protein-3 functions in liver of normal rats 113
Age-related changes in renal and hepatic cellular mechanisms associated with variations in rat serum thyroid hormone levels 112
Absence of Uncoupling Protein-3 at Thermoneutrality Impacts Lipid Handling and Energy Homeostasis in Mice 112
Acute administration of 3,5-diiodo-L-thyronine to hypothyroid rats affects bioenergetic parameters in rat skeletal muscle mitochondria 112
“A Proteomics Approach to Identify Protein Expression Changes in Rat Liver Following Administration of 3,5,3'-Triiodo-l-thyronine.” 110
In vitro binding of 3,5-diiodo-L-thyronine to rat liver mitochondria 110
Direct and rapid effects of 3,5-diiodo-L-thyronine (T2) 110
3,5-diiodo-L-thyronine, by modulatine mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet 110
Cold exposure induces different uncoupling protein thermogenin masking-unmasking processes in brown adipose tissue depending on mitochondrial subtypes 109
Sequential changes in the signal transduction responses of skeletal muscle following food deprivation 109
Metabolic effects of thyroid hormone derivatives 109
Control of energy metabolism by iodothyronines 108
Characterization of specific mitochondrial binding sites for 3,3'-diiodo-L-thyronine 106
Fasting, lipid metabolism and triiodothyronine in rat gastrocnemius muscle: interrelated roles of uncoupling protein 3, mitochondrial thioesterase and coenzyme Q 105
Activation and inactivation of thyroid hormone by type I iodothyronine deiodinase 105
Insight on the body fat lowering effect of 3,5-Diiodo-L-Thyronine 105
Pathways affected by 3,5-diiodo-L-thyronine in liver of high fat-fed rats: Evidence from two-dimensional electrophoresis, blue-native PAGE, and mass spectrometry 104
Fuel economy in food-deprived skeletal muscle: signaling pathways and regulatory mechanisms 104
Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats 103
Thyroid-state influence on protein-expression profile of rat skeletal muscle 102
Biochemical and functional differences in rat liver mitochondrial subpopulations obtained at different gravitational forces 102
Metabolic effects of the iodothyronine functional analogue TRC150094 on the liver and skeletal muscle of high-fat diet fed overweight rats: an integrated proteomic study. 101
Changes in the functional proteomic profiles of rat skeletal muscles after caloric restriction and catch-up fat upon refeeding 100
Rapid stimulation in vitro of rat liver cytochrome oxidase activity by 3,5-diiodo-L-thyronine and by 3,3'-diiodo-L-thyronine 99
Absence of uncoupling protein 3 at thermoneutrality influences brown adipose tissue mitochondrial functionality in mice 98
Effect of 3,5-diiodo-L-thyronine on thyroid stimulating hormone and growth hormone serum levels in hypothyroid rats. 95
Indentification by photoaffinity labeling of 3,5-diiodo-L-thyronine-binding proteins in rat liver cytosol 95
Relationship between dose, mode of administration and effects of triiodothyronine on two hepatic responsive enzymes 95
Studies of Complex Biological Systems with Applications to Molecular Medicine: the Need to Integrate Transcriptomic and Proteomic Approaches 91
ORGAN-SPECIFIC RESPONSE TO HIGH-FAT DIET AND 3,5-DIIODOTHYRONINE (T2) TREATMENT; A POSSIBLE INVOLVEMENT OF THE AMP-ACTIVATED PROTEIN KINASE (AMPK)., 91
THE DEGREE OF FATTY ACID SATURATION INFLUENCES THE EFFECTS OF T3 AND 3,5-T2 ON INSULIN SENSITIVITY IN MUSCLE CELLS 91
Uncoupling proteins 2 and 3 influence obesità and inflammation in transgenic mice 89
Differential deranged liver pathways in genetically determined thyroid dysfunctions: intra- and extrahepatic factors. . 88
Combined cDNA array/RT-PCR analysis of gene expression profile in rat gastrocnemius muscle: relation to its adaptive function in energy metabolism during fasting 87
Insights into sarcopenia: interrelation between protein profiles and mitochondrial functionality in rat ageing skeletal muscle 86
Interrelated influence of superoxides and free fatty acids over mitochondrial uncoupling in skeletal muscle 86
The thyroid hormone metabolite 3,5-diiodo-l-thyronine prevents hepatic fat accumulation and systemic insulin resistance through direct activation of sirtuin 1 (SIRT1) 86
Brain Abnormalities in Young Single- and Double-Heterozygote Mice for Both Nkx2-1- and Pax8-Null Mutations 85
Combined effect of gender and caloric restriction on liver proteomic expression profile 85
How thyroid controls metabolism: a different role for triiodothyronine and for diiodothyronines 85
Thyroid hormone analogues and derivatives: Actions in fatty liver 85
Temporal relationship between organ responses to 3,5-diiodo-L-thyronine in high-fat diet-fed rats role of AMPK 85
Pax8 and Nkx2-1 haploinsufficiencies differentially affect liver metabolic pathways 85
Role of AMPK in the organ-specific responses to 3,5-diiodo-L-thyronine in high-fat diet-fed rats 84
Metabolic action of thyroid hormones: insights from functional and proteomic studies 83
PPARs: Nuclear Receptors Controlled by, and Controlling, Nutrient Handling through Nuclear and Cytosolic Signaling. 83
Exercise with food withdrawal at thermoneutrality impacts fuel use, the microbiome, AMPK phosphorylation, muscle fibers, and thyroid hormone levels in rats 83
Nonthyrotoxic prevention of diet-induced insulin resistance by 3,5-diiodo-L-thyronine in rats. 80
Responses of skeletal muscle lipid metabolism in rat gastrocnemius to hypothyroidism and iodothyronine administration: a putative role for FAT/CD36 80
Expression of uncoupling protein-3 and mitochondrial activity in the transition from hypothyroid to hyperthyroid state in rat skeletal muscle 79
Altered Mitochondrial Quality Control in Rats with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Induced by High-Fat Feeding 79
Composition including 3,5-diiodothyronine and pharmacological use of them 78
Differential 3,5,3'-triiodothyronine-mediated regulation of uncoupling protein 3 transcription: role of Fatty acids 78
Uncoupling protein 3 expression levels influence insulin sensitivity, fatty acid oxidation, and related signaling pathways. 78
High expression of thyroid hormone receptors and mitochondrial glycerol-3-phosphate dehydrogenase in the liver is linked to enhanced fatty acid oxidation in Lou/C rat strain resistant to obesity 77
Specific binding sites for 3,3'-diiodo-L-thyronine (3,3'-T2) in rat liver mitochondria 77
TRC150094, a novel functional analogue of iodothyronines, reduces adiposity by increasing energy expenditure and fatty acid oxidation in rats receiving a high-fat diet 77
Intracellular and plasma membrane-initiated pathways involved in the [Ca2+]i elevations induced by iodothyronines (T3 and T2) in pituitary GH3 cells 76
Uncoupling protein-3 is a molecular determinant for the regulation of resting metabolic rate by thyroid hormone 75
Skeletal muscle mitochondrial free-fatty acid content and membrane potential sensitivity in different thyroid states: involvement of uncoupling protein 3 and adenine nucleotide translocase 75
Uncoupling protein-3 (UCP3) translocates lipid hydroperoxide and mediates lipid hydroperoxide-dependent mitochondrial uncoupling 75
Mild Endurance Exercise during Fasting Increases Gastrocnemius Muscle and Prefrontal Cortex Thyroid Hormone Levels through Differential BHB and BCAA-Mediated BDNF-mTOR Signaling in Rats 74
Non genomic effects of 3,5,3-L-triiodothyronina through AMPK/ACC and AKT/PKB signaling: relation to changes in fuel metabolism and myosin heavy chain protein content in rat gastrocnemius muscle in vivo 73
Exercise Equals the Mobilization of Visceral versus Subcutaneous Adipose Fatty Acid Molecules in Fasted Rats Associated with the Modulation of the AMPK/ATGL/HSL Axis 72
The effect of 3,5 diiodo-L-thyronine on mitochondrial energetic transduction apparatus 71
Rapid activation by 3,5,3'-L-triiodothyronine of adenosine 5'-monophosphate-activated protein kinase/acetyl-coenzyme a carboxylase and akt/protein kinase B signaling pathways: relation to changes in fuel metabolism and myosin heavy-chain protein content in rat gastrocnemius muscle in vivo 70
Mammalian mitochondrial proteome and its functions: current investigative techniques and future perspectives on ageing and diabetes 70
Mitochondrial function and thyroid hormones 70
Triiodothyronine modulates the expression of aquaporin 8 in rat liver mitochondria 69
Totale 10.586
Categoria #
all - tutte 66.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.561


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021333 0 0 0 0 0 0 0 0 0 114 208 11
2021/2022513 14 6 284 21 7 14 16 70 40 6 16 19
2022/20231.549 233 53 39 188 134 289 4 142 311 38 78 40
2023/2024599 44 146 85 22 28 28 6 36 112 28 6 58
2024/20252.319 131 39 110 74 325 142 125 325 266 265 295 222
2025/20264.102 305 427 581 312 231 287 754 262 521 422 0 0
Totale 11.443